Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Soligenix begins phase II trial of SGX-942 for the treatment of oral mucositis

Dec. 12, 2013

Interleukin Genetics to launch PerioPredict periodontal disease test

Nov. 28, 2013

Clinical characterization of a novel pleiotropic anti-inflammatory effect of high-dose statin

Oct. 22, 2013

Acacia Pharma's phase II trial of APD-515 for xerostomia meets primary endpoint

Oct. 15, 2013

C3 Jian completes phase I trial of therapeutic for prevention of tooth decay

Aug. 23, 2013

FDA grants fast track designation to SGX-942

June 4, 2013

Sosei initiates phase III study of mucoadhesive buccal tablet for oropharyngeal candidiasis

March 12, 2013

C3 Jian completes enrollment for phase I study of candidate for cavity prevention

Feb. 20, 2013

PolyMedix receives NCI grant to study brilacidin for oral mucositis

Sep. 20, 2012

Dara BioSciences acquires exclusive U.S. right to Gelclair

Sep. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 6, 2025.
Regenxbio’s Duchenne gene therapy data positive as shares falter
BioWorld
Regenxbio Inc.’s gene therapy in treating Duchenne muscular dystrophy (DMD) produced positive initial phase I/II results from its first five patients. However,...
EMA warns Ozempic linked to ‘very rare’ side effect
BioWorld
The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in which...
Aiatella secures €2M for AI-based cardiovascular imaging tech
BioWorld MedTech
Aiatella Oy secured €2 million (US$2.28 million) in funding for its AI-powered cardiovascular imaging technology. The funds will be used to conduct clinical...